Total Funding
$46M
Employee Range
1-10
Veralox Therapeutics develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type one diabetes. Based on an understanding of the molecular mechanisms of these diseases, these efforts will lead to new treatment paradigms and better outcomes for patients.
Veralox Therapeutics data powered by:
Share
Veralox Therapeutics data powered by:
Veralox TherapeuticsOverall Ranking
National Rank
Share
Loading...
In United States
Top null%out of startups
Regional Rank
Share
Loading...
In North America
Top null%out of startups
Veralox TherapeuticsIndustry Rankings in
Healthtech
City Rank
Share
3rd
In Frederick
Top 30%out of 10 startups
National Rank
Share
3,599th
In United States
Top 41%out of 8865 startups
Regional Rank
Share
3,799th
In North America
Top 40%out of 9661 startups
Veralox TherapeuticsSubindustry Rankings in
BiotechnologyCity Rank
Share
3rd
In Frederick
Top 50%out of 6 startups
National Rank
Share
1,598th
In United States
Top 47%out of 3469 startups
Regional Rank
Share
1,668th
In North America
Top 45%out of 3717 startups
rankings by:
Veralox TherapeuticsSB Rank Evolution
Not enough data points to display the chart.
Veralox TherapeuticsstartupComparison
National Ranking (undefined)
Loading...
...
Regional Ranking (undefined)
Loading...
...
Global Ranking (WorldWide)
Loading...
...
Industry Ranking (undefined)
Loading...
...
SubIndustry Ranking (undefined)
Loading...
...
See all ranked entities with a premium subscription
Get Pro